Presentation is loading. Please wait.

Presentation is loading. Please wait.

Funding Opportunities European Commission - Horizon 2020 Wallenberg Foundations National Institutes of Health NIH Research Professional Anna Lobell -

Similar presentations


Presentation on theme: "Funding Opportunities European Commission - Horizon 2020 Wallenberg Foundations National Institutes of Health NIH Research Professional Anna Lobell -"— Presentation transcript:

1 Funding Opportunities European Commission - Horizon 2020 Wallenberg Foundations National Institutes of Health NIH Research Professional Anna Lobell - Krister Halldin - Anders Alderborn - Carolina Rydin - Sofia Wretblad - Ulrika Huss Melin

2 UU ”Grants Office” Swedish grants Government, private
Centralized proposals Evaluations Research Officers Web Research Professional Call portal Manuals, forms Research Officers Financial Unit European Union Identify calls Proposal, negotiation Implementation EU Research Officers UU ”Grants Office” American grants NIH etc Proposals Reporting Research Officers Financial Issues Budget calculation Financial reporting Audit Financial Unit Innovation & patent Patent Commersialisation Business collaborations UU Innovation Legal Issues Contract IPR Copyright Legal Unit

3 Comparison of funding agencies
2013 Millions of SEK Årsrapport 2014 UKÄ

4 Income MedFarm 2010-12 (tkr) ongoing and new contracts
Agency (sorted on size 2012) 2010 2011 2012 Vetenskapsrådet Cancerfonden 52 801 57 843 51 694 EU (FP7, exkl ERC) 18 025 31 044 44 967 Formas 17 669 23 415 35 301 K&A Wallenberg Stiftelse 27 586 23 236 25 192 Vinnova 38 285 22 718 24 386 ERC (FP7) 23 755 SIDA 19 765 18 591 19 378 SSF 22 069 22 359 21 023 Uppsala Akademiförvaltning 4 353 10 257 12 454 FAS 11 740 6 019 8 880 Others (privata stiftelser o fonder, amerikanska, företag mm) 145939 169588 158976 Totalt 498455 536482 593105

5 EU Framework Programmes
To strengthen European competitiveness, economic growth and employment Based on “Knowledge Triangle” Programmes: FP1 to FP7, 1984 – 2013 Horizon 2020, 2014 – 2020 Research & Technology Knowledge triangle Education Innovation

6 Main goals Strengthen the EU’s position in science
Boost top-level research Strengthen European industry, in particular small companies (SMEs) Greater access to capital and support for SMEs Remove obstacles in industrial innovation Address major European concerns (“societal challenges”) Health problems, aging population, food safety, environment etc Bridge the gap between research, healthcare and market

7 2014-2020, €80 billion HORIZON 2020 39% 32% 21% 3. Societal Challenges
2. Industrial leadership 32% 1. Excellent Science 21% HORIZON 2020

8 HORIZON 2020 3. Societal Challenges 2. Industrial leadership
Health, demographic change and well-being Food security, sustainable agriculture and forestry, marine and maritime and inland water research, and the bioeconomy Secure, clean and efficient energy Smart, green and integrated transport Climate action, environment, resource efficiency and raw materials Europe in a changing world - inclusive, innovative and reflective societies Secure societies - protecting freedom and security of Europe and its citizens European Research Council Marie Skłodowska-Curie Actions Future and Emerging Technologies Research Infrastructures Enabling and industrial technologies Innovation in SME Access to Risk Finance 3. Societal Challenges 2. Industrial leadership 1. Excellent Science HORIZON 2020

9 Prio 1 - Excellent Science
European Research Council (ERC) Marie Skłodowska-Curie Actions (MSCA) Future and Emerging Technologies (FET) Research Infrastructures (RI)

10 ERC (European Research Council)
Basic frontier research, “bottom-up” (like VR) Project types: Starting Grant 2-7 years from dissertation, ≤1.5 M€ over 5 years Consolidator Grant 8-12 years from dissertation, ≤2 M€ over 5 years Advanced Grant ≤2,5 (3,5) M€ over 5 years Synergy Grant 2 - 4 researchers, ≤15 M€ over 5 years Proof of Concept ≤150 k€ over 1 year Bridge gap between research and a marketable innovation Can be used as recruitment instrument from any country

11 ERC (European Research Council)
Basic frontier research, “bottom-up” (like VR) Project types: Starting Grant 2-7 years from dissertation, ≤1.5 M€ over 5 years Consolidator Grant 8-12 years from dissertation, ≤2 M€ over 5 years Advanced Grant ≤2,5 (3,5) M€ over 5 years Proof of Concept Grant ≤150 k€ over 1 year For ERC Grant holders to investigate innovation potential Can be used as recruitment instrument from any country

12 Marie Skłodowska-Curie Actions (People in FP7)
Education, career development for researchers Mobility within, to and outside Europe Broadened interaction between industry and academia Bottom-up programmes

13 Marie Skłodowska-Curie Actions
IF – Individual Fellowships Research in an (another) EU country (1-2 years) Research outside EU (1-2 years) and within EU again (1 year) ITN – Innovative Training Networks European “Research Training school” (5 – 10 partners) - ETN Joint doctorate between Universities - EJD Industry doctorate (in conjunction with university) - EID RISE – Research and Innovation Staff Exchange Knowledge exchange by two-way secondments Researcher PhD stud, Researcher PhD stud, Researcher, Lab staff Can be used as recruitment instrument from any country

14 Future Emerging Technologies (FET)
Collaborative research to support radically new technological possibilities to “shape the future technology landscape” Three lines: FET Open FET Proactive FET Flagships Early-stage, visionary new ideas (bottom-up) Based on challenges (top-down) Large-scale initiatives in areas of European interest

15 Infrastructures Create and coordinate European facilities, resources and services for research and innovation, e.g. Equipment, biobanks, databases Single site, distributed or virtual Based on ESFRI roadmap Top-down programme ESFRI = European Strategy Forum on Research Infrastructures

16 Prio 2 – Industrial leadership
Leadership in enabling and industrial technologies Innovation in SME Access to Risk Finance

17 Leadership in enabling and industrial technologies
Collaborative projects to build industrial leadership within prioritized areas: ICT (Information and Communication Technologies) Nanotechnologies Advanced materials Biotechnology Advanced manufacturing  and processing Space Bridge the gap between research and marketable products and services Top-down programme (needs in industry)

18 Innovation in SME Access to Risk Finance
Funding to SMEs, entrepreneur coaching, IPR helpdesk etc May involve collaboration with University Access to Risk Finance Loans, risk finance, bank guarantees to companies

19 Prio 3 – Societal challenges
Health, demographic change and well-being Food security, sustainable agriculture and forestry, marine and maritime and inland water research, and the bioeconomy Secure, clean and efficient energy Smart, green and integrated transport Climate action, environment, resource efficiency and raw materials Europe in a changing world - inclusive, innovative and reflective societies Secure societies - protecting freedom and security of Europe and its citizens

20 Funding schemes Research and Innovation Action
Coordination and support E.g. networking, support services, standardisations Innovation Action Close-to-market research SME instrument Tailored support to SMEs to develop innovative ideas Fast track to innovation Short project to speed up time from idea to market Prizes ERA-NET Applied for by national funders

21 Research and Innovation Action
Collaborations between academia, industry and healthcare ≥3 (often 5 – 15) partners from ≥3 countries Participate as coordinator or partner Project budget ≈2 – 6 M€ (20M€) Three evaluation criteria: Science Impact Implementation ”Top-down” program. SMEs often important Denna får justeras

22 What is different from FP7?
Health => Health, demography and wellbeing Broader topics => greater freedom to suggest solutions More emphasis on bridging the gap between academia, healthcare and market Open innovation Higher participation of industry, healthcare and authorities Clinical research more important Stronger emphasis on expected impact Correlate to EU strategies Important with networking!

23 Funding rates 100% of direct costs 25% overhead
However, companies in Innovation actions: 70% of direct costs 25% OH

24 More Information http://ec.europa.eu/research/participants/portal

25

26 HORIZON 2020 3. Societal Challenges 2. Industrial leadership
Health, demographic change and well-being Food security, sustainable agriculture and forestry, marine and maritime and inland water research, and the bioeconomy Secure, clean and efficient energy Smart, green and integrated transport Climate action, environment, resource efficiency and raw materials Europe in a changing world - inclusive, innovative and reflective societies Secure societies - protecting freedom and security of Europe and its citizens European Research Council Marie Skłodowska-Curie Actions Future and Emerging Technologies Research Infrastructures Enabling and industrial technologies Innovation in SME Access to Risk Finance 3. Societal Challenges 2. Industrial leadership 1. Excellent Science COST EIT European Institute of innovation & Technology EuroStars 2 Partnership Programs, PPP, JPI, JTI (e.g. IMI 2) JRC Joint Research Centre HORIZON 2020

27 Innovative Medicines Initiative 2 (IMI 2)
Cooperation between the commission and drug industry (via EFPIA) = PPP Possibly extended into other areas of life science in IMI2 “Pre-competitive” research for improved drugs E.g. clinical trial design, new antibiotics, common stem cell bank ≥3 (often 5 – 15) partners from ≥3 countries ”Top-down” program

28 COST COST = Network projects within 36 COST countries
Funding for project meetings, conferences, travel, accommodation, (not research) Strengthen cooperation and defragmentation in Europe Capacity building by promoting early-career researchers ”Bottom-up” program

29 Upcoming deadlines Program Deadline
Personalising health and care October 14 ERC Advanced Grant October 21 IMI2 (T1DM therapy, macular degeneration and diabetic retinopathy) November 12 Marie Curie ITN January 13 ERC Starting Grant February 3 Personalising health and care February 24 ERC Consolidator Grant March 12

30 Newsletter about upcoming calls

31 Influence upcoming calls
Contact and support EU Anders Alderborn, PhD, Assoc Prof Find EU programme Apply Negotiate Implement project Report Influence upcoming calls Krister Halldin, PhD Anna Lobell, PhD, Assoc Prof Offices at BMC, A2 floor 1

32 https://mp.uu.se/web/info/forska/forskarservice

33

34

35

36

37

38 Note VR Grants for international recruitment of leading researchers (<15 mkr/year, 10 years) VR International Career Grants, April X Wallenberg Academy Fellows, Jan X (Head of Dept nominates) Workshop for Young Researchers applying to VR (start up seminar 3 Dec) FORTE – more focus on health/welfare issues

39 VR Medicin och hälsa 2013 Summa projektbidrag 2008 – 2013 (inkl
VR Medicin och hälsa 2013 Summa projektbidrag 2008 – 2013 (inkl. unga forskare) i kr för hela anslagsperioden (3 – 6 år), de fem största lärosätena

40 VR MH 2013 – Projektbidrag (inkl
VR MH 2013 – Projektbidrag (inkl. unga forskare), antal ansökningar och antal beviljade (12 lärosäten)

41 VR MH 2013 – Projektbidrag unga forskare, antal ansökningar och antal beviljade (12 lärosäten)

42 VR MH 2011-2013 Projektbidrag unga forskare (alla) Antal beviljade Summa kronor
MH Unga forskare 2011 2012 2013 KI 39 26 15 GU 14 9 1 LU 12 13 5 UU 6 3 2 UmU 7 LiU SU SLU ÖU Summa antal beviljade, summa belopp 84 55

43 Contact and support National funding bodies
Carolina Rydin, PhD National funding bodies Centrally coordinated applications Applications signed by the Vice-Chancellor The Wallenberg Foundations (KAW, MMW, MAW) US Funding Opportunities (NIH, NSF, USAID etc) Sofia Wretblad, PhD Ulrika Huss Melin, PhD Offices at St: Olofsgatan


Download ppt "Funding Opportunities European Commission - Horizon 2020 Wallenberg Foundations National Institutes of Health NIH Research Professional Anna Lobell -"

Similar presentations


Ads by Google